Who is moving to which position
Resolved 1 April 2026Incoming appointee
1 itemDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
To strengthen the business structure in the SES business area and pursue initiatives beyond the existing framework, the Company will appoint a person with a record of achievements in another industry as the company's representative director.
To strengthen the SES business structure by leveraging experience and achievements in the pharmaceutical and CSO industries.
| Item | Details |
|---|---|
| Resolution date | 1 April 2026 |
| Scheduled Appointment Date | 1 April 2026 |
| Name of appointee | Nozawa Midori (野澤 美登利) |
| Appointee's new position | 株式会社ブレーンナレッジシステムズ Representative Director and President |
| Appointee's previous position | CMIC MPSS Co., Ltd. (now CMIC Inizio), General Manager, CSO Company Division |
| Appointee's date of birth | 28 January 1981 |
| Name of departing officer | Tominaga Kuniaki (富永 邦昭) |
| Former position of departing officer | 株式会社ブレーンナレッジシステムズ Representative Director and President |
| New position of departing officer | Human Creation Holdings,Inc. Representative Director and President |
| Reason for change | To strengthen the business structure in the SES business area and pursue initiatives beyond the existing framework, the Company will appoint a person with a record of achievements in another industry as the company's representative director. |
| Reasons for appointment | To strengthen the SES business structure by leveraging experience and achievements in the pharmaceutical and CSO industries. |
| Subject to Approval by the General Meeting of Shareholders | The appointment of directors was approved at the extraordinary general meeting of shareholders held on 1 April 2026. The meeting has already been held; this is not a scheduled meeting date. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the business structure in the SES business area. Nozawa was appointed representative director to pursue initiatives beyond the existing framework, drawing on her record of achievements in the pharmaceutical and CSO industries.